ABN AMRO BANK NV-CVA (AB2.DE) Fundamental Analysis & Valuation

FRA:AB2 • NL0011540547

Current stock price

29.49 EUR
-0.39 (-1.31%)
Last:

This AB2.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AB2.DE Profitability Analysis

1.1 Basic Checks

  • AB2 had positive earnings in the past year.
  • AB2 had a positive operating cash flow in the past year.
  • Each year in the past 5 years AB2 has been profitable.
  • In multiple years AB2 reported negative operating cash flow during the last 5 years.
AB2.DE Yearly Net Income VS EBIT VS OCF VS FCFAB2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B 40B

1.2 Ratios

  • AB2's Return On Assets of 0.49% is on the low side compared to the rest of the industry. AB2 is outperformed by 70.75% of its industry peers.
  • With a Return On Equity value of 7.53%, AB2 is not doing good in the industry: 63.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.49%
ROE 7.53%
ROIC N/A
ROA(3y)0.59%
ROA(5y)0.51%
ROE(3y)9.02%
ROE(5y)8%
ROIC(3y)N/A
ROIC(5y)N/A
AB2.DE Yearly ROA, ROE, ROICAB2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 21.78%, AB2 is in line with its industry, outperforming 46.23% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AB2 has remained more or less at the same level.
  • AB2 does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 21.78%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.32%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AB2.DE Yearly Profit, Operating, Gross MarginsAB2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AB2.DE Health Analysis

2.1 Basic Checks

  • AB2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AB2 has less shares outstanding
  • The number of shares outstanding for AB2 has been reduced compared to 5 years ago.
  • AB2 has a better debt/assets ratio than last year.
AB2.DE Yearly Shares OutstandingAB2.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
AB2.DE Yearly Total Debt VS Total AssetsAB2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B

2.2 Solvency

  • AB2 has a debt to FCF ratio of 51.19. This is a negative value and a sign of low solvency as AB2 would need 51.19 years to pay back of all of its debts.
  • AB2 has a Debt to FCF ratio (51.19) which is in line with its industry peers.
  • A Debt/Equity ratio of 2.78 is on the high side and indicates that AB2 has dependencies on debt financing.
  • AB2's Debt to Equity ratio of 2.78 is on the low side compared to the rest of the industry. AB2 is outperformed by 73.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF 51.19
Altman-Z N/A
ROIC/WACCN/A
WACC7.53%
AB2.DE Yearly LT Debt VS Equity VS FCFAB2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
AB2.DE Yearly Current Assets VS Current LiabilitesAB2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AB2.DE Growth Analysis

3.1 Past

  • AB2 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.89%.
  • AB2 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.87% yearly.
  • The Revenue has decreased by -2.44% in the past year.
  • The Revenue has been growing slightly by 1.47% on average over the past years.
EPS 1Y (TTM)-8.89%
EPS 3Y7.87%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-2.44%
Revenue growth 3Y3.28%
Revenue growth 5Y1.47%
Sales Q2Q%-6.73%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.70% on average over the next years. This is quite good.
  • Based on estimates for the next years, AB2 will show a small growth in Revenue. The Revenue will grow by 3.74% on average per year.
EPS Next Y14.31%
EPS Next 2Y17.51%
EPS Next 3Y18.32%
EPS Next 5Y11.7%
Revenue Next Year7.02%
Revenue Next 2Y6.53%
Revenue Next 3Y5.6%
Revenue Next 5Y3.74%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AB2.DE Yearly Revenue VS EstimatesAB2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
AB2.DE Yearly EPS VS EstimatesAB2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. AB2.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.99, which indicates a very decent valuation of AB2.
  • Compared to the rest of the industry, the Price/Earnings ratio of AB2 indicates a slightly more expensive valuation: AB2 is more expensive than 64.15% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, AB2 is valued rather cheaply.
  • AB2 is valuated reasonably with a Price/Forward Earnings ratio of 10.49.
  • Based on the Price/Forward Earnings ratio, AB2 is valued a bit cheaper than 61.32% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.24. AB2 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.99
Fwd PE 10.49
AB2.DE Price Earnings VS Forward Price EarningsAB2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AB2 indicates a somewhat cheap valuation: AB2 is cheaper than 67.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.18
EV/EBITDA N/A
AB2.DE Per share dataAB2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AB2's earnings are expected to grow with 18.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y17.51%
EPS Next 3Y18.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. AB2.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.13%, AB2 is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 4.47, AB2 has a dividend in line with its industry peers.
  • AB2's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 4.13%

5.2 History

  • The dividend of AB2 decreases each year by -1.32%.
Dividend Growth(5Y)-1.32%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 53.32% of the earnings are spent on dividend by AB2. This is a bit on the high side, but may be sustainable.
DP53.32%
EPS Next 2Y17.51%
EPS Next 3Y18.32%
AB2.DE Yearly Income VS Free CF VS DividendAB2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B 40B
AB2.DE Dividend Payout.AB2.DE Dividend Payout, showing the Payout Ratio.AB2.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AB2.DE Fundamentals: All Metrics, Ratios and Statistics

ABN AMRO BANK NV-CVA

FRA:AB2 (4/23/2026, 7:00:00 PM)

29.49

-0.39 (-1.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-11
Earnings (Next)05-13
Inst Owners47.28%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap18.76B
Revenue(TTM)9.35B
Net Income(TTM)2.04B
Analysts74.78
Price Target35.04 (18.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.13%
Yearly Dividend1.31
Dividend Growth(5Y)-1.32%
DP53.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.38%
Min EPS beat(2)-22.97%
Max EPS beat(2)2.21%
EPS beat(4)3
Avg EPS beat(4)-4.09%
Min EPS beat(4)-22.97%
Max EPS beat(4)2.3%
EPS beat(8)6
Avg EPS beat(8)6.36%
EPS beat(12)10
Avg EPS beat(12)17.27%
EPS beat(16)14
Avg EPS beat(16)36.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.73%
Min Revenue beat(2)-5.2%
Max Revenue beat(2)-2.25%
Revenue beat(4)0
Avg Revenue beat(4)-2.87%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)-1.33%
Revenue beat(8)4
Avg Revenue beat(8)3.64%
Revenue beat(12)8
Avg Revenue beat(12)5.5%
Revenue beat(16)12
Avg Revenue beat(16)8.62%
PT rev (1m)1.27%
PT rev (3m)7.84%
EPS NQ rev (1m)1.77%
EPS NQ rev (3m)10.25%
EPS NY rev (1m)0.94%
EPS NY rev (3m)2.56%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-3.21%
Revenue NY rev (1m)0.88%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE 11.99
Fwd PE 10.49
P/S 2.01
P/FCF 10.18
P/OCF 8.39
P/B 0.69
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)2.46
EY8.34%
EPS(NY)2.81
Fwd EY9.54%
FCF(TTM)2.9
FCFY9.82%
OCF(TTM)3.51
OCFY11.91%
SpS14.69
BVpS42.51
TBVpS41.95
PEG (NY)0.84
PEG (5Y)N/A
Graham Number48.5045 (64.48%)
Profitability
Industry RankSector Rank
ROA 0.49%
ROE 7.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.78%
GM N/A
FCFM 19.72%
ROA(3y)0.59%
ROA(5y)0.51%
ROE(3y)9.02%
ROE(5y)8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.32%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF 51.19
Debt/EBITDA N/A
Cap/Depr 217.78%
Cap/Sales 4.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 90.57%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)205.27%
Cap/Depr(5y)165.85%
Cap/Sales(3y)4.02%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.89%
EPS 3Y7.87%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y14.31%
EPS Next 2Y17.51%
EPS Next 3Y18.32%
EPS Next 5Y11.7%
Revenue 1Y (TTM)-2.44%
Revenue growth 3Y3.28%
Revenue growth 5Y1.47%
Sales Q2Q%-6.73%
Revenue Next Year7.02%
Revenue Next 2Y6.53%
Revenue Next 3Y5.6%
Revenue Next 5Y3.74%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y116.39%
FCF growth 3YN/A
FCF growth 5Y-47.24%
OCF growth 1Y120.7%
OCF growth 3YN/A
OCF growth 5Y-45.22%

ABN AMRO BANK NV-CVA / AB2.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABN AMRO BANK NV-CVA (AB2.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AB2.DE.


What is the valuation status of ABN AMRO BANK NV-CVA (AB2.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to ABN AMRO BANK NV-CVA (AB2.DE). This can be considered as Fairly Valued.


How profitable is ABN AMRO BANK NV-CVA (AB2.DE) stock?

ABN AMRO BANK NV-CVA (AB2.DE) has a profitability rating of 2 / 10.


What is the valuation of ABN AMRO BANK NV-CVA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABN AMRO BANK NV-CVA (AB2.DE) is 11.99 and the Price/Book (PB) ratio is 0.69.


Can you provide the financial health for AB2 stock?

The financial health rating of ABN AMRO BANK NV-CVA (AB2.DE) is 2 / 10.